Chronic Disease Management Market Overview
The Chronic Disease Management (CDM) marketplace specializes in enhancing affected person outcomes, decreasing healthcare costs, and improving quality of life via long-time period tracking and remedy solutions for conditions together as diabetes, cardiovascular diseases, cancer, and breathing disorders. Rising incidence of chronic illnesses, an ageing population, and the shift in the direction of value-primarily based totally healthcare models are driving the adoption of CDM programs. Integration of virtual fitness equipment like telemedicine, far-flung tracking devices, and AI-powered analytics is, in addition, remodelling patient care. Additionally, developing authorities initiatives, repayment support, and growing collaboration amongst healthcare carriers and era agencies are fuelling market expansion globally.
Global Chronic Disease Management Market size was valued at USD 6137.4 million in 2024 and is expected to reach at USD 15937.4 million in 2033, with a CAGR of 14.2% during the forecast period of 2025 to 2033.
Looking For Tailored Insights? Request Your Customized Report Today: https://foreclaroglobalresearch.com/research-report/global-chronic-disease-management-market/sample
Top Players
· TriZetto Corporation
· IBM
· Pegasystems Inc.
· EXL Healthcare
· AxisPoint Health
· Wellcentive, Inc.
· Medecision, Inc.
· i2i Systems, Inc.
· HealthSmart Holdings, Inc.
· Allscripts Healthcare Solutions, Inc.
· ZeOmega Inc.
· Epic Corporation Inc.
Foreclaro Global Research published a new research publication on Global Chronic Disease Management Market, offers a detailed overview of the factors influencing the global business scope. Chronic Disease Management Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Chronic Disease Management.
The Global Chronic Disease Management Market segments and Market Data Break Down are illuminated below:
By Disease Type (Cardiovascular Diseases, Diabetes, Chronic Respiratory Diseases, Cancer, Chronic Kidney Disease, Neurological Disorders, Arthritis & Musculoskeletal Disorders, Mental Health Conditions, Other Chronic Conditions), By Component (Software & Solutions {Electronic Health Records (EHR) Integration, Clinical Decision Support Systems, Patient Engagement Solutions, Remote Patient Monitoring Platforms, Analytics & Reporting Tools}, Services {Consulting & Implementation, Training & Education, Support & Maintenance}, Hardware {Remote Monitoring Devices, Wearable Medical Devices, Mobile Health Devices}), By Mode of Delivery (On-Premises Solutions, Cloud-Based Solutions, Web-Based Platforms), By End User (Healthcare Providers, Payers, Patients/Individuals, Employers & Corporate Wellness Programs, Research Institutions), By Intervention Type (Preventive Care Management, Chronic Care Management, Rehabilitation Services, Palliative Care), By Technology (Telehealth & Telemedicine, mHealth (Mobile Health), Artificial Intelligence & Machine Learning, Big Data & Analytics, IoT & Connected Devices, Blockchain for Health Data Security)
Recent Developments
· In September 2025, Roche agreed to buy biotech firm 89bio for up to $3.5 billion in 2025. The acquisition is aimed at metabolic dysfunction-associated steatohepatitis (MASH), which is tied to chronic conditions like type 2 diabetes and obesity.
· In April 2025, DarioHealth entered a strategic partnership with a national benefit plan administrator to offer its cardiometabolic solution, including a GLP-1 support program, to employers. This has already begun contributing to recurring revenues.
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Get Data That Fits Your Business – Enquire Now for Report Customization: https://foreclaroglobalresearch.com/research-report/global-chronic-disease-management-market/enquiry
Points Covered in Table of Content of Global Chronic Disease Management Market:
Chapter 01 - Chronic Disease Management Executive Summary
Chapter 02 - Market Overview
Chapter 03 - Key Success Factors
Chapter 04 - Global Chronic Disease Management Market - Pricing Analysis
Chapter 05 - Global Chronic Disease Management Market Background or History
Chapter 06 - Global Chronic Disease Management Market Segmentation (e.g. Type, Application)
Chapter 07 - Key and Emerging Countries Analysis Worldwide Chronic Disease Management Market
Chapter 08 - Global Chronic Disease Management Market Structure & worth Analysis
Chapter 09 - Global Chronic Disease Management Market Competitive Analysis & Challenges
Chapter 10 - Assumptions and Acronyms
Chapter 11 - Chronic Disease Management Market Research Methodology
Finally, Chronic Disease Management Market is a valuable source of guidance for individuals and companies in decision framework.
Research Methodology
At Foreclaro Global Research, our research methodology is firmly rooted in a comprehensive and systematic approach to market research. We leverage a blend of reliable public and proprietary data sources, including industry reports, government publications, company filings, trade journals, investor presentations, and credible online databases. Our analysts critically evaluate and triangulate information to ensure accuracy, consistency, and depth of insights. We follow a top-down and bottom-up data modelling framework to estimate market sizes and forecasts, supplemented by competitive benchmarking and trend analysis. Each research output is tailored to client needs, backed by transparent data validation practices, and continuously refined to reflect dynamic market conditions.
Don’t Settle For Generic Data – Customize This Report To Your Needs Speak with Analyst: https://foreclaroglobalresearch.com/research-report/global-chronic-disease-management-market/speak
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.
Contact US:
Gazala S. (Sales Head)
A 507, Neco Beaumont, NIBM Annexe,
Pune, Maharashtra – 411060
